Á lódáil...
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure. Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no systematic trial has been undertaken to support its use in ABMR. In this randomized, placebo-controlled trial (the Borte...
Na minha lista:
| Foilsithe in: | J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
American Society of Nephrology
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791086/ https://ncbi.nlm.nih.gov/pubmed/29242250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2017070818 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|